Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 17 de 17
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Elife ; 92020 03 24.
Artigo em Inglês | MEDLINE | ID: mdl-32207683

RESUMO

The cardiac ventricular action potential depends on several voltage-gated ion channels, including NaV, CaV, and KV channels. Mutations in these channels can cause Long QT Syndrome (LQTS) which increases the risk for ventricular fibrillation and sudden cardiac death. Polyunsaturated fatty acids (PUFAs) have emerged as potential therapeutics for LQTS because they are modulators of voltage-gated ion channels. Here we demonstrate that PUFA analogues vary in their selectivity for human voltage-gated ion channels involved in the ventricular action potential. The effects of specific PUFA analogues range from selective for a specific ion channel to broadly modulating cardiac ion channels from all three families (NaV, CaV, and KV). In addition, a PUFA analogue selective for the cardiac IKs channel (Kv7.1/KCNE1) is effective in shortening the cardiac action potential in human-induced pluripotent stem cell-derived cardiomyocytes. Our data suggest that PUFA analogues could potentially be developed as therapeutics for LQTS and cardiac arrhythmia.


Assuntos
Canais de Cálcio Tipo L/efeitos dos fármacos , Ácidos Graxos Insaturados/farmacologia , Canal de Potássio KCNQ1/efeitos dos fármacos , Canal de Sódio Disparado por Voltagem NAV1.5/efeitos dos fármacos , Canais de Potássio de Abertura Dependente da Tensão da Membrana/efeitos dos fármacos , Proteínas de Xenopus/efeitos dos fármacos , Potenciais de Ação/efeitos dos fármacos , Animais , Antiarrítmicos/farmacologia , Canais de Cálcio Tipo L/fisiologia , Células-Tronco Pluripotentes Induzidas/citologia , Canal de Potássio KCNQ1/fisiologia , Síndrome do QT Longo/tratamento farmacológico , Miócitos Cardíacos/efeitos dos fármacos , Canal de Sódio Disparado por Voltagem NAV1.5/fisiologia , Canais de Potássio de Abertura Dependente da Tensão da Membrana/fisiologia , Proteínas de Xenopus/fisiologia , Xenopus laevis
2.
Acta Trop ; 174: 56-63, 2017 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-28666890

RESUMO

Growing concern on the application of synthetic mosquito repellents in the recent years has instigated the identification and development of better alternatives to control different mosquito-borne diseases. In view of above, present investigation evaluates the repellent activity of ethyl anthranilate (EA), a non-toxic, FDA approved volatile food additive against three known mosquito vectors namely, Aedes aegypti, Anopheles stephensi and Culex quinquefasciatus under laboratory conditions following standard protocols. Three concentration levels (2%, 5% and 10% w/v) of EA were tested against all the three selected mosquito species employing K & D module and arm-in-cage method to determine the effective dose (ED50) and complete protection time (CPT), respectively. The repellent activity of EA was further investigated by modified arm-in-cage method to determine the protection over extended spatial ranges against all mosquito species. All behavioural situations were compared with the well-documented repellent N,N-diethylphenyl acetamide (DEPA) as a positive control. The findings demonstrated that EA exhibited significant repellent activity against all the three mosquitoes species. The ED50 values of EA, against Aedes aegypti, Anopheles stephensi and Culex quinquefasciatus were found to be 0.96%, 5.4% and 3.6% w/v, respectively. At the concentration of 10% w/v, it provided CPTs of 60, 60 and 30min, respectively, against Aedes aegypti, Anopheles stephensi and Culex quinquefasciatus mosquitoes. Again in spatial repellency evaluation, EA was found to be extremely effective in repelling all the three tested species of mosquitoes. Ethyl anthranilate provided comparable results to standard repellent DEPA during the study. Results have concluded that the currently evaluated chemical, EA has potential repellent activity against some well established mosquito vectors. The study emphasizes that repellent activity of EA could be exploited for developing effective, eco-friendly, acceptable and safer alternative to the existing harmful repellents for personal protection against different hematophagous mosquito species.


Assuntos
Aedes/efeitos dos fármacos , Anopheles/efeitos dos fármacos , Culex/efeitos dos fármacos , Repelentes de Insetos/farmacologia , Mosquitos Vetores/efeitos dos fármacos , ortoaminobenzoatos/farmacologia , Animais , Proteínas do Tecido Nervoso/efeitos dos fármacos , Proteínas de Xenopus/efeitos dos fármacos
3.
Psychopharmacology (Berl) ; 231(17): 3493-501, 2014 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-24553581

RESUMO

RATIONALE: Neurosteroids and likely other lipid modulators access transmembrane sites on the GABAA receptor (GABAAR) by partitioning into and diffusing through the plasma membrane. Therefore, specific components of the plasma membrane may affect the potency or efficacy of neurosteroid-like modulators. Here, we tested a possible role for phosphatidylinositol 4,5-bisphosphate (PIP2), a phospholipid that governs activity of many channels and transporters, in modulation or function of GABAARs. OBJECTIVES: In these studies, we sought to deplete plasma-membrane PIP2 and probe for a change in the strength of potentiation by submaximal concentrations of the neurosteroid allopregnanolone (3α5αP) and other anesthetics, including propofol, pentobarbital, and ethanol. We also tested for a change in the behavior of negative allosteric modulators pregnenolone sulfate and dipicrylamine. METHODS: We used Xenopus oocytes expressing the ascidian voltage-sensitive phosphatase (Ci-VSP) to deplete PIP2. Voltage pulses to positive membrane potentials were used to deplete PIP2 in Ci-VSP-expressing cells. GABAARs composed of α1ß2γ2L and α4ß2δ subunits were challenged with GABA and 3α5αP or other modulators before and after PIP2 depletion. KV7.1 channels and NMDA receptors (NMDARs) were used as positive controls to verify PIP2 depletion. RESULTS: We found no evidence that PIP2 depletion affected modulation of GABAARs by positive or negative allosteric modulators. By contrast, Ci-VSP-induced PIP2 depletion depressed KV7.1 activation and NMDAR activity. CONCLUSIONS: We conclude that despite a role for PIP2 in modulation of a wide variety of ion channels, PIP2 does not affect modulation of GABAARs by neurosteroids or related compounds.


Assuntos
Neurotransmissores/farmacologia , Fosfatidilinositol 4,5-Difosfato/metabolismo , Receptores de GABA-A/efeitos dos fármacos , Animais , Feminino , Canal de Potássio KCNQ1/efeitos dos fármacos , Oócitos , Técnicas de Patch-Clamp , Fosfatidilinositol 4,5-Difosfato/deficiência , Picratos/farmacologia , Canais de Potássio de Abertura Dependente da Tensão da Membrana/efeitos dos fármacos , Pregnenolona/farmacologia , Receptores de N-Metil-D-Aspartato/efeitos dos fármacos , Xenopus , Proteínas de Xenopus/efeitos dos fármacos , Ácido gama-Aminobutírico/farmacologia
4.
Br J Nutr ; 109(8): 1389-95, 2013 Apr 28.
Artigo em Inglês | MEDLINE | ID: mdl-22932126

RESUMO

The water-soluble B vitamins, folate and folic acid, play an important role in reproductive health, but little is known about the effects of folic acid on infertility. The present study tested the hypothesis that folic acid affects oocyte maturation, a possible cause of female infertility. We have studied the in vitro maturation of mouse and Xenopus oocytes. Hypoxanthine (Hx) was used as an inhibitor of mouse oocyte maturation to mimic in vivo conditions by maintaining high levels of cyclic-AMP. The frequency of first polar body (PB1) formation and germinal vesicle breakdown (GVBD) in mouse oocytes was decreased by Hx. This effect was counteracted by folic acid added to the medium. PB1 extrusion and GVBD percentages rose to 27·7 and 40·0% from 12·8 and 19·9%, respectively, by exposure to 500 µM-folic acid. Folic acid also restored the spindle configuration, which had been elongated by Hx, as well as normalising the distribution of cortical granules (CG). In folic acid-treated Xenopus eggs, extracellular signal-regulated kinase 1 was phosphorylated, cyclin B2 and Mos were up-regulated and the frequency of GVBD was accelerated. Taken together, the findings suggest that folic acid facilitates oocyte maturation by altering the expression and phosphorylation of proteins involved in M-phase-promoting factor and mitogen-activated protein kinase pathways, as well as causing changes in spindle configuration and CG migration.


Assuntos
Ácido Fólico/farmacologia , Fator Promotor de Maturação/metabolismo , Meiose/efeitos dos fármacos , Proteína Quinase 3 Ativada por Mitógeno/metabolismo , Proteínas Quinases Ativadas por Mitógeno/metabolismo , Oócitos/efeitos dos fármacos , Análise de Variância , Animais , Núcleo Celular/metabolismo , Células Cultivadas , AMP Cíclico/metabolismo , Ciclina B2/efeitos dos fármacos , Ciclina B2/metabolismo , Feminino , Hipoxantina/farmacologia , Infertilidade Feminina/etiologia , Infertilidade Feminina/metabolismo , Camundongos , Oócitos/crescimento & desenvolvimento , Proteínas de Xenopus/efeitos dos fármacos , Proteínas de Xenopus/metabolismo , Xenopus laevis
5.
Neuroscience ; 182: 232-40, 2011 May 19.
Artigo em Inglês | MEDLINE | ID: mdl-21402126

RESUMO

The effects of isoflurane on the modulation of two neuronal voltage-gated calcium channels (Ca(v); Ca(v)2.1 and 2.2) by protein kinase C (PKC) isozymes ßII, ε or δ and their combination were examined. Ca(v)2.1α1 or Ca(v)2.2α1 with ß1b and α2δ subunits were expressed in Xenopus oocytes and the currents (I(Ba)) were recorded by two-electrode voltage clamp. Isoflurane (0.70 mM) decreased both Ca(v)2.1 and 2.2 currents by 20-35% and also caused translocation of PKCδ to the membrane. Compared to the wild type (WT), isoflurane caused greater inhibition of Ca(v)2.2 currents in the absence of stimulatory PKC sites (Thr-422, Ser-1757, Ser-2108, Ser-2132) and in the presence of inhibitory PKC site (Ser-425). In contrast, isoflurane caused less inhibition of I(Ba) in the oocytes expressing S425A, the inhibitory site mutant, compared to WT. PKCδ by itself did not modulate Ca(v)2.2 currents, but potentiated these currents in the presence of isoflurane. PKCε increased Ca(v)2.2 currents either alone or in combination with isoflurane. Ca(v)2.1 currents were not modulated by phorbol-12-myristate, 13-acetate (PMA) or acetyl-ß-methylcholine (MCh), activators of PKC. Yet the presence of isoflurane caused PMA (but not MCh) to enhance Ca(v)2.1 currents. PKCßII and PKCε isozymes activated by PMA, did not alter Ca(v)2.1 currents. However, in the presence of isoflurane, these two isozymes together potentiated Ca(v)2.1 currents. The variable responses of Ca(v)2.1 currents to PKCßII and PKCε and Ca(v)2.2 currents to PKCδ in the presence of isoflurane may be due to increased affinity or accessibility of these isozymes to their Ser/Thr PKC sites of Ca(v)α1 subunits.


Assuntos
Anestésicos Inalatórios/farmacologia , Canais de Cálcio Tipo N/metabolismo , Ativação Enzimática/efeitos dos fármacos , Isoflurano/farmacologia , Oócitos/metabolismo , Proteína Quinase C-delta/metabolismo , Proteínas de Xenopus/metabolismo , Animais , Canais de Cálcio Tipo N/efeitos dos fármacos , Canais de Cálcio Tipo N/genética , Ativação Enzimática/fisiologia , Feminino , Oócitos/efeitos dos fármacos , Fosforilação/efeitos dos fármacos , Fosforilação/fisiologia , Proteína Quinase C-delta/química , Proteína Quinase C-delta/genética , Subunidades Proteicas/efeitos dos fármacos , Subunidades Proteicas/genética , Subunidades Proteicas/metabolismo , Proteínas de Xenopus/efeitos dos fármacos , Proteínas de Xenopus/genética , Xenopus laevis
6.
J Gen Physiol ; 136(1): 63-82, 2010 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-20548052

RESUMO

Interactions of the three transported Na ions with the Na/K pump remain incompletely understood. Na/K pump crystal structures show that the extended C terminus of the Na,K-adenosine triphosphatase (ATPase) alpha subunit directly contacts transmembrane helices. Deletion of the last five residues (KETYY in almost all Na/K pumps) markedly lowered the apparent affinity for Na activation of pump phosphorylation from ATP, a reflection of cytoplasmic Na affinity for forming the occluded E1P(Na3) conformation. ATPase assays further suggested that C-terminal truncations also interfere with low affinity Na interactions, which are attributable to extracellular effects. Because extracellular Na ions traverse part of the membrane's electric field to reach their binding sites in the Na/K pump, their movements generate currents that can be monitored with high resolution. We report here electrical measurements to examine how Na/K pump interactions with extracellular Na ions are influenced by C-terminal truncations. We deleted the last two (YY) or five (KESYY) residues in Xenopus laevis alpha1 Na/K pumps made ouabain resistant by either of two kinds of point mutations and measured their currents as 10-mM ouabain-sensitive currents in Xenopus oocytes after silencing endogenous Xenopus Na/K pumps with 1 microM ouabain. We found the low affinity inhibitory influence of extracellular Na on outward Na/K pump current at negative voltages to be impaired in all of the C-terminally truncated pumps. Correspondingly, voltage jump-induced transient charge movements that reflect pump interactions with extracellular Na ions were strongly shifted to more negative potentials; this signals a several-fold reduction of the apparent affinity for extracellular Na in the truncated pumps. Parallel lowering of Na affinity on both sides of the membrane argues that the C-terminal contacts provide important stabilization of the occluded E1P(Na3) conformation, regardless of the route of Na ion entry into the binding pocket. Gating measurements of palytoxin-opened Na/K pump channels additionally imply that the C-terminal contacts also help stabilize pump conformations with occluded K ions.


Assuntos
Potássio/metabolismo , ATPase Trocadora de Sódio-Potássio/fisiologia , Sódio/metabolismo , Tirosina/fisiologia , Acrilamidas/farmacologia , Substituição de Aminoácidos/fisiologia , Animais , Ligação Competitiva/fisiologia , Venenos de Cnidários , Fenômenos Eletrofisiológicos/efeitos dos fármacos , Fenômenos Eletrofisiológicos/fisiologia , Ativação do Canal Iônico/efeitos dos fármacos , Ativação do Canal Iônico/fisiologia , Potenciais da Membrana/fisiologia , Oócitos/metabolismo , Ouabaína/farmacologia , Técnicas de Patch-Clamp , Venenos/farmacologia , Ligação Proteica/fisiologia , Conformação Proteica/efeitos dos fármacos , RNA Complementar/genética , Deleção de Sequência/fisiologia , ATPase Trocadora de Sódio-Potássio/efeitos dos fármacos , Proteínas de Xenopus/efeitos dos fármacos , Proteínas de Xenopus/fisiologia , Xenopus laevis
7.
Chemosphere ; 77(3): 308-12, 2009 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-19683326

RESUMO

The present investigation examines the effects of the marine toxins, okadaic acid (OA) and palytoxin (PTX), on some genes involved in the neural and muscular specification and patterning of Xenopus laevis. The RT-PCR analyses performed at different stages of embryonic and larval development (stages 11-47) demonstrated that both toxins induce an over-expression of the genes siamois and engrailed-2 and a different behaviour in bmp4 and myf5. Indeed, OA provoked a significant increase in bmp4 in the earliest stage (11) examined, a down-regulation from stages 12 to 17, and a renewed increase from the beginning of hatching onwards (stages 35-47). In contrast, myf5 was up-regulated in all stages up to 35. PTX induced an over-expression of both bmp4 and myf5 during the embryonic and early larval development stages. The results show that PTX induces an increase in expression levels in all tested genes, while the response to OA seems to be more stage-dependent, with the embryonic development stage more sensitive to the toxin than the larval stages.


Assuntos
Acrilamidas/toxicidade , Desenvolvimento Embrionário/efeitos dos fármacos , Regulação da Expressão Gênica no Desenvolvimento/efeitos dos fármacos , Genes Controladores do Desenvolvimento/efeitos dos fármacos , Toxinas Marinhas/toxicidade , Ácido Okadáico/toxicidade , Proteínas de Xenopus/metabolismo , Animais , Proteína Morfogenética Óssea 4/genética , Proteína Morfogenética Óssea 4/metabolismo , Venenos de Cnidários , Embrião não Mamífero/efeitos dos fármacos , Proteínas de Homeodomínio/genética , Proteínas de Homeodomínio/metabolismo , Fator Regulador Miogênico 5/genética , Fator Regulador Miogênico 5/metabolismo , Proteínas do Tecido Nervoso/genética , Proteínas do Tecido Nervoso/metabolismo , Testes de Toxicidade , Proteínas de Xenopus/efeitos dos fármacos , Proteínas de Xenopus/genética , Xenopus laevis
8.
Neuroscience ; 159(2): 618-28, 2009 Mar 17.
Artigo em Inglês | MEDLINE | ID: mdl-19167461

RESUMO

Ca(v)2.2 high voltage-gated calcium channels are regulated by phorbol-12-myristae, 13-acetate (PMA) via Ser/Thr protein kinase C (PKC) phosphorylation sites in the I-II linker and C-terminus of the alpha(1) 2.2 subunit. Here we show that PMA enhancement of Ca(v)2.2 currents expressed in Xenopus oocytes can be blocked by inhibitors of PKC betaII or PKC epsilon isozymes, as shown previously for Ca(v)2.3 currents, and that microinjection of PKC betaII or PKC epsilon isozymes in the oocytes expressing the WT Ca(v)2.2 channels increases the basal barium current (I(Ba)). The I-V plot shows a large increase in current amplitude with PKC betaII and PKC epsilon isozymes with only a small shift in the peak I(Ba) in the hyperpolarizing direction. The potentiation of Ca(v)2.2 currents by microinjection of PKC betaII and PKC epsilon isozymes was not altered by the inhibition of G proteins with GDPbetaS. The combination of isozyme specific inhibitors with previously generated Ser/Thr to Ala mutants of alpha(1) 2.2 subunit revealed that PKC betaII or PKC epsilon isozymes (but not PKC alpha or delta) can provide full enhancement through the stimulatory site (Thr-422) in the I-II linker but that PKC epsilon is better at decreasing channel activity through the inhibitory site Ser-425. The enhancing effect of PKC betaII or epsilon at Thr-422 is dominant over the inhibitory effect at Ser-425. Injected PKC betaII also enhances Ca(v)2.2 current when any of the potential stimulatory sites (Ser-1757, Ser-2108 and Ser-2132) are available in the C-terminus. PKC epsilon provides lesser enhancement with C-terminal sites and only with Ser-2108 and Ser-2132. Sites Ser-1757 and Ser-2132, but not Ser-2108, are dominant over the inhibitory site Ser-425. Collectively, these results reveal a hierarchy of regulatory sites in Ca(v)2.2 channels. Site-specific regulation by different PKC isozymes may allow graded levels of channel activation and susceptibility or resistance to subsequent stimulatory events.


Assuntos
Canais de Cálcio Tipo N/metabolismo , Regulação da Expressão Gênica/fisiologia , Proteína Quinase C-épsilon/metabolismo , Proteína Quinase C/metabolismo , Proteínas de Xenopus/metabolismo , Animais , Ácido Aspártico/genética , Canais de Cálcio Tipo N/efeitos dos fármacos , Canais de Cálcio Tipo N/genética , Relação Dose-Resposta a Droga , Ativação Enzimática/efeitos dos fármacos , Ativação Enzimática/genética , Inibidores Enzimáticos/farmacologia , Feminino , Regulação da Expressão Gênica/efeitos dos fármacos , Guanosina Difosfato/análogos & derivados , Guanosina Difosfato/farmacologia , Potenciais da Membrana/efeitos dos fármacos , Potenciais da Membrana/genética , Microinjeções/métodos , Mutação/genética , Oócitos , Técnicas de Patch-Clamp , Ésteres de Forbol/farmacologia , Fosforilação/genética , Proteína Quinase C/genética , Proteína Quinase C/farmacologia , Proteína Quinase C beta , Proteína Quinase C-épsilon/genética , Proteína Quinase C-épsilon/farmacologia , Estrutura Terciária de Proteína/fisiologia , RNA Interferente Pequeno/farmacologia , Serina/genética , Serina/metabolismo , Tionucleotídeos/farmacologia , Treonina/genética , Proteínas de Xenopus/efeitos dos fármacos , Proteínas de Xenopus/genética , Xenopus laevis
9.
Pharmazie ; 63(6): 475-9, 2008 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-18604993

RESUMO

As the major component of I(to) (slow), Kv1.4 channel plays an important role in repolarization of cardiac myocytes. C-type inactivation is one of Kv1.4 inactivation and can be affected by open channel blockers. We used the two-electrode voltage clamp technique to observe the effect of amiodarone on Kv1.4 C-type inactivation and compare amiodarone's effects on Kv1.4 with propafenone and verapamil. Our data show that those three antiarrhythmic drugs blocked fKv1.4 delta N (N-terminal deleted Kv1.4 channel from ferret heart) in voltage- and frequent-dependent manners. The amiodarone's IC50 was 489.23 +/- 4.72 microM, higher than that of propafenone (98.97 +/- 1.13 microM) and verapamil (263.26 +/- 6.89 microM) for fKv1.4 delta N channel (+50 mV). After application of amiodarone, propafenone and verapamil, fKv1.4 delta N inactivation becomes bi-exponential: the faster portion of inactivation (drug-induced inactivation) and the slower portion of inactivation (C-type inactivation). Amiodarone and verapamil fastened C-type inactivation in fKv1.4 delta N, but propafenone did not. Unlike propafenone that had no effect on fKv1.4 delta N recovery, amiodarone and verapamil slowed recovery in fKv1.4 delta N.


Assuntos
Amiodarona/farmacologia , Antiarrítmicos/farmacologia , Bloqueadores dos Canais de Cálcio/farmacologia , Canal de Potássio Kv1.4/efeitos dos fármacos , Propafenona/farmacologia , Verapamil/farmacologia , Proteínas de Xenopus/efeitos dos fármacos , Animais , DNA Complementar/biossíntese , DNA Complementar/genética , Relação Dose-Resposta a Droga , Eletrofisiologia , Feminino , Oócitos/efeitos dos fármacos , Oócitos/metabolismo , Técnicas de Patch-Clamp , Xenopus laevis
10.
J Cell Physiol ; 210(2): 479-88, 2007 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-17111367

RESUMO

Mutations in the gene encoding ClC-5 lead to X-linked hypercalciuric nephrolithiasis (XLHN), characterized by proteinuria, hypercalciuria, and phosphaturia. In renal proximal tubule cells, ClC-5 was identified as an important player in endocytosis, which ensures reabsorption of filtered protein. However, the recent finding that ClC-5 is a Cl(-)/H(+) antiporter and not a Cl(-) channel as long thought points to the lack of understanding of its functional role. Also, little biochemical data are available about ClC-5 and its post-translational modifications have not been investigated. Here, we examined the role of N-glycosylation of xClC-5 in the Xenopus oocyte expression system by comparing wild-type (WT) xClC-5 and N-glycosylation site mutants. We found that xClC-5 is N-glycosylated on asparagines 169 and 470, which are the only N-glycosylated sites. xClC-5 mutants have an increased susceptibility to polyubiquitination and proteasomal degradation; however, without a notable impact on the expression level. Using a cross-linking reagent, we showed that xClC-5 assembles into protein complexes, independent of its N-glycosylation. Voltage-clamp measurements showed a reduced conductance in the presence of tunicamycin and with xClC-5 N-glycosylation site mutants. Using immunocytochemistry, we localized xClC-5 mainly in intracellular compartments, and found that its cell surface pool is reduced in the absence of N-glycans. We further examined the plasma membrane retrieval of WT and mutant xClC-5 in the presence of Brefeldin A (BFA), and found that the non-glycosylated mutant was retrieved more than five times faster than the WT protein. We conclude that N-glycosylation enhances cell surface expression of xClC-5, increasing its plasma membrane transport activity.


Assuntos
Membrana Celular/metabolismo , Canais de Cloreto/metabolismo , Proteínas de Xenopus/metabolismo , Animais , Asparagina/metabolismo , Membrana Celular/efeitos dos fármacos , Membrana Celular/genética , Canais de Cloreto/efeitos dos fármacos , Canais de Cloreto/genética , Cloretos/metabolismo , Feminino , Glicosilação/efeitos dos fármacos , Líquido Intracelular/efeitos dos fármacos , Líquido Intracelular/metabolismo , Substâncias Macromoleculares/metabolismo , Potenciais da Membrana/efeitos dos fármacos , Potenciais da Membrana/genética , Mutação/genética , Oócitos/metabolismo , Técnicas de Patch-Clamp , Polissacarídeos/metabolismo , Polissacarídeos/farmacologia , Complexo de Endopeptidases do Proteassoma/metabolismo , Inibidores da Síntese de Proteínas/farmacologia , Transporte Proteico/efeitos dos fármacos , Transporte Proteico/genética , Fatores de Tempo , Proteínas de Xenopus/efeitos dos fármacos , Proteínas de Xenopus/genética , Xenopus laevis
11.
J Cell Biol ; 173(5): 673-83, 2006 Jun 05.
Artigo em Inglês | MEDLINE | ID: mdl-16754955

RESUMO

In late mitosis and early G1, replication origins are licensed for subsequent use by loading complexes of the minichromosome maintenance proteins 2-7 (Mcm2-7). The number of Mcm2-7 complexes loaded onto DNA greatly exceeds the number of replication origins used during S phase, but the function of the excess Mcm2-7 is unknown. Using Xenopus laevis egg extracts, we show that these excess Mcm2-7 complexes license additional dormant origins that do not fire during unperturbed S phases because of suppression by a caffeine-sensitive checkpoint pathway. Use of these additional origins can allow complete genome replication in the presence of replication inhibitors. These results suggest that metazoan replication origins are actually comprised of several candidate origins, most of which normally remain dormant unless cells experience replicative stress. Consistent with this model, using Caenorhabditis elegans, we show that partial RNAi-based knockdown of MCMs that has no observable effect under normal conditions causes lethality upon treatment with low, otherwise nontoxic, levels of the replication inhibitor hydroxyurea.


Assuntos
Replicação do DNA/fisiologia , Estresse Oxidativo/fisiologia , Origem de Replicação , Proteínas de Xenopus/metabolismo , Adenosina Trifosfatases/efeitos dos fármacos , Adenosina Trifosfatases/metabolismo , Animais , Afidicolina/farmacologia , Caenorhabditis elegans/efeitos dos fármacos , Caenorhabditis elegans/crescimento & desenvolvimento , Cafeína/farmacologia , Proteínas de Transporte/efeitos dos fármacos , Proteínas de Transporte/metabolismo , Proteínas de Ciclo Celular/efeitos dos fármacos , Proteínas de Ciclo Celular/metabolismo , Sobrevivência Celular/efeitos dos fármacos , Cromatina/efeitos dos fármacos , Cromatina/metabolismo , Replicação do DNA/efeitos dos fármacos , Proteínas de Ligação a DNA/efeitos dos fármacos , Proteínas de Ligação a DNA/metabolismo , Hidroxiureia/farmacologia , Componente 2 do Complexo de Manutenção de Minicromossomo , Componente 3 do Complexo de Manutenção de Minicromossomo , Componente 4 do Complexo de Manutenção de Minicromossomo , Componente 7 do Complexo de Manutenção de Minicromossomo , Proteínas Nucleares/efeitos dos fármacos , Proteínas Nucleares/metabolismo , Fatores de Tempo , Proteínas de Xenopus/efeitos dos fármacos , Xenopus laevis
12.
Mol Cell Biol ; 26(5): 1997-2011, 2006 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-16479016

RESUMO

We previously used a soluble cell-free system derived from Xenopus eggs to investigate the role of protein phosphatase 2A (PP2A) in chromosomal DNA replication. We found that immunodepletion of PP2A or inhibition of PP2A by okadaic acid (OA) inhibits initiation of DNA replication by preventing loading of the initiation factor Cdc45 onto prereplication complexes. Evidence was provided that PP2A counteracts an inhibitory protein kinase that phosphorylates and inactivates a crucial Cdc45 loading factor. Here, we report that the inhibitory effect of OA is abolished by caffeine, an inhibitor of the checkpoint kinases ataxia-telangiectasia mutated protein (ATM) and ataxia-telangiectasia related protein (ATR) but not by depletion of ATM or ATR from the extract. Furthermore, we demonstrate that double-strand DNA breaks (DSBs) cause inhibition of Cdc45 loading and initiation of DNA replication and that caffeine, as well as immunodepletion of either ATM or ATR, abolishes this inhibition. Importantly, the DSB-induced inhibition of Cdc45 loading is prevented by addition of the catalytic subunit of PP2A to the extract. These data suggest that DSBs and OA prevent Cdc45 loading through different pathways, both of which involve PP2A, but only the DSB-induced checkpoint implicates ATM and ATR. The inhibitory effect of DSBs on Cdc45 loading does not result from downregulation of cyclin-dependent kinase 2 (Cdk2) or Cdc7 activity and is independent of Chk2. However, it is partially dependent on Chk1, which becomes phosphorylated in response to DSBs. These data suggest that PP2A counteracts ATM and ATR in a DNA damage checkpoint in Xenopus egg extracts.


Assuntos
Proteínas de Ciclo Celular/metabolismo , Quinase 2 Dependente de Ciclina/metabolismo , Dano ao DNA/fisiologia , Proteínas de Ligação a DNA/metabolismo , Fosfoproteínas Fosfatases/metabolismo , Proteínas Serina-Treonina Quinases/metabolismo , Proteínas Supressoras de Tumor/metabolismo , Proteínas de Xenopus/metabolismo , Animais , Proteínas Mutadas de Ataxia Telangiectasia , Cafeína/farmacologia , Proteínas de Ciclo Celular/efeitos dos fármacos , Quinase 1 do Ponto de Checagem , Quinase do Ponto de Checagem 2 , Quinase 2 Dependente de Ciclina/efeitos dos fármacos , DNA/genética , DNA/metabolismo , Replicação do DNA/efeitos dos fármacos , Proteínas de Ligação a DNA/efeitos dos fármacos , Feminino , Ácido Okadáico/farmacologia , Fosfoproteínas Fosfatases/efeitos dos fármacos , Proteínas Quinases/efeitos dos fármacos , Proteínas Quinases/metabolismo , Proteína Fosfatase 2 , Proteínas Serina-Treonina Quinases/efeitos dos fármacos , Proteínas Supressoras de Tumor/efeitos dos fármacos , Proteínas de Xenopus/efeitos dos fármacos , Proteínas de Xenopus/genética
13.
Zygote ; 13(1): 23-30, 2005 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-15984158

RESUMO

Aurora-A is a serine/threonine protein kinase that plays important regulatory roles during mitotic cell cycle progression. In this study, Aurora-A expression, subcellular localization, and possible functions during porcine oocyte meiotic maturation, fertilization and early embryonic cleavage were studied by using Western blot, confocal microscopy and drug treatments. The quantity of Aurora-A protein remained stable during porcine oocyte meiotic maturation. Confocal microscopy revealed that Aurora-A distributed abundantly in the nucleus at the germinal vesicle stage. After germinal vesicle breakdown, Aurora-A concentrated around the condensed chromosomes and the metaphase I spindle, and finally, Aurora-A was associated with spindle poles during the formation of the metaphase II spindle. Aurora-A concentrated in the pronuclei in fertilized eggs. Aurora-A was not found in the spindle region when colchicine or staurosporine was used to inhibit microtubule organization, while it accumulated as several dots in the cytoplasm after taxol treatment. In conclusion, Aurora-A may be a multifunctional kinase that plays pivotal regulatory roles in microtubule assembly during porcine oocyte meiotic maturation, fertilization and early embryonic mitosis.


Assuntos
Proteínas de Ciclo Celular/metabolismo , Fase de Clivagem do Zigoto/enzimologia , Meiose , Oócitos/fisiologia , Proteínas Quinases/metabolismo , Proteínas de Xenopus/metabolismo , Animais , Aurora Quinases , Ciclo Celular/fisiologia , Proteínas de Ciclo Celular/efeitos dos fármacos , Proteínas de Ciclo Celular/fisiologia , Células Cultivadas , Fase de Clivagem do Zigoto/fisiologia , Colchicina/farmacologia , Embrião de Mamíferos/enzimologia , Embrião de Mamíferos/fisiologia , Feminino , Fertilização in vitro , Microtúbulos/efeitos dos fármacos , Microtúbulos/metabolismo , Mitose , Oócitos/citologia , Oócitos/efeitos dos fármacos , Paclitaxel/farmacologia , Proteínas Quinases/efeitos dos fármacos , Proteínas Quinases/fisiologia , Proteínas Serina-Treonina Quinases , Fuso Acromático/metabolismo , Estaurosporina/farmacologia , Frações Subcelulares , Suínos , Proteínas de Xenopus/efeitos dos fármacos , Proteínas de Xenopus/fisiologia
14.
Nat Neurosci ; 8(6): 730-5, 2005 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-15880110

RESUMO

Calcium arising through release from intracellular stores and from influx across the plasma membrane is essential for signalling by specific guidance cues and by factors that inhibit axon regeneration. The mediators of calcium influx in these cases are largely unknown. Transient receptor potential channels (TRPCs) belong to a superfamily of Ca2+-permeable, receptor-operated channels that have important roles in sensing and responding to changes in the local environment. Here we report that XTRPC1, a Xenopus homolog of mammalian TRPC1, is required for proper growth cone turning responses of Xenopus spinal neurons to microscopic gradients of netrin-1, brain-derived neurotrophic factor and myelin-associated glycoprotein, but not to semaphorin 3A. Furthermore, XTRPC1 is required for midline guidance of axons of commissural interneurons in the developing Xenopus spinal cord. Thus, members of the TRPC family may serve as a key mediator for the Ca2+ influx that regulates axon guidance during development and inhibits axon regeneration in adulthood.


Assuntos
Canais de Cálcio/metabolismo , Sinalização do Cálcio/fisiologia , Diferenciação Celular/fisiologia , Quimiotaxia/fisiologia , Cones de Crescimento/metabolismo , Sistema Nervoso/embriologia , Proteínas de Xenopus/metabolismo , Animais , Fator Neurotrófico Derivado do Encéfalo/metabolismo , Fator Neurotrófico Derivado do Encéfalo/farmacologia , Canais de Cálcio/efeitos dos fármacos , Sinalização do Cálcio/efeitos dos fármacos , Comunicação Celular/fisiologia , Diferenciação Celular/efeitos dos fármacos , Movimento Celular/efeitos dos fármacos , Movimento Celular/fisiologia , Quimiotaxia/efeitos dos fármacos , Sinais (Psicologia) , Embrião não Mamífero , Lateralidade Funcional/fisiologia , Cones de Crescimento/efeitos dos fármacos , Cones de Crescimento/ultraestrutura , Inibidores do Crescimento/metabolismo , Interneurônios/citologia , Interneurônios/metabolismo , Glicoproteína Associada a Mielina/metabolismo , Glicoproteína Associada a Mielina/farmacologia , Fatores de Crescimento Neural/metabolismo , Fatores de Crescimento Neural/farmacologia , Regeneração Nervosa/efeitos dos fármacos , Regeneração Nervosa/fisiologia , Sistema Nervoso/citologia , Sistema Nervoso/metabolismo , Netrina-1 , Medula Espinal/citologia , Medula Espinal/embriologia , Medula Espinal/metabolismo , Canais de Cátion TRPC , Proteínas Supressoras de Tumor/metabolismo , Proteínas Supressoras de Tumor/farmacologia , Proteínas de Xenopus/efeitos dos fármacos , Xenopus laevis
15.
Mol Endocrinol ; 19(7): 1720-39, 2005 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-15718292

RESUMO

The pregnane X receptor (PXR) regulates the metabolism and elimination of bile salts, steroids, and xenobiotics. The sequence of the PXR ligand-binding domain diverges extensively between different animals, suggesting interspecies differences in ligands. Of the endogenous ligands known to activate PXR, biliary bile salts vary the most across vertebrate species, ranging from 27-carbon (C27) bile alcohol sulfates (early fish, amphibians) to C24 bile acids (birds, mammals). Using a luciferase-based reporter assay, human PXR was activated by a wide variety of bile salts. In contrast, zebrafish PXR was activated efficiently only by cyprinol sulfate, the major zebrafish bile salt, but not by recent bile acids. Chicken, mouse, rat, and rabbit PXRs were all activated by species-specific bile acids and by early fish bile alcohol sulfates. In addition, phylogenetic analysis using maximum likelihood demonstrated evidence for nonneutral evolution of the PXR ligand-binding domain. PXR activation by bile salts has expanded from narrow specificity for C27 bile alcohol sulfates (early fish) to a broader specificity for recent bile acids (birds, mammals). PXR specificity for bile salts has thus paralleled the increasing complexity of the bile salt synthetic pathway during vertebrate evolution, an unusual example of ligand-receptor coevolution in the nuclear hormone receptor superfamily.


Assuntos
Ácidos e Sais Biliares/farmacologia , Evolução Molecular , Receptores Citoplasmáticos e Nucleares/agonistas , Receptores Citoplasmáticos e Nucleares/classificação , Receptores de Esteroides/agonistas , Receptores de Esteroides/classificação , Animais , Ácidos e Sais Biliares/química , Ácidos e Sais Biliares/fisiologia , Colestanóis/farmacologia , Humanos , Camundongos , Estrutura Molecular , Filogenia , Receptor de Pregnano X , Coelhos , Ratos , Receptores Citoplasmáticos e Nucleares/efeitos dos fármacos , Receptores Citoplasmáticos e Nucleares/genética , Receptores de Esteroides/genética , Especificidade da Espécie , Proteínas de Xenopus/efeitos dos fármacos , Xenopus laevis , Peixe-Zebra
16.
J Cell Sci ; 116(Pt 13): 2697-705, 2003 Jul 01.
Artigo em Inglês | MEDLINE | ID: mdl-12746489

RESUMO

Deadenylation is an intimate part of the post-transcriptional regulation of maternal mRNAs in embryos. EDEN-BP is so far the only known member of a complex regulating the deadenylation of maternal mRNA in Xenopus laevis embryos in a manner that is dependent on the 3'-untranslated region called EDEN (embryo deadenylation element). In this report, we show that calcium activation of cell-free extracts triggers EDEN binding protein (EDEN-BP) dephosphorylation and concomitant deadenylation of a chimeric RNA bearing Aurora A/Eg2 EDEN sequence. Deadenylation of mRNA deprived of EDEN sequence (default deadenylation) does not change with egg activation. Kinase and phosphatase inhibitors downregulate EDEN-dependent deadenylation but they do not substantially influence default deadenylation. Using indestructible Delta90 cyclin B to revert interphase extracts to the M-phase, we show that modulation of EDEN-dependent deadenylation is independent of M-phase promoting factor (MPF) activity. These results suggest that the increase in EDEN-dependent deadenylation following egg activation is achieved, at least partially, via dephosphorylation and/or phosphorylation of regulatory proteins, including EDEN-BP dephosphorylation. This regulation proceeds in a manner independent from MPF inactivation.


Assuntos
Monofosfato de Adenosina/metabolismo , Oócitos/metabolismo , Proteínas Quinases/genética , RNA Mensageiro Estocado/metabolismo , Proteínas de Ligação a RNA/metabolismo , Proteínas de Xenopus/metabolismo , Regiões 3' não Traduzidas/genética , Monofosfato de Adenosina/química , Animais , Aurora Quinases , Cálcio/química , Cálcio/farmacologia , Sinalização do Cálcio/efeitos dos fármacos , Sinalização do Cálcio/genética , Proteínas de Ciclo Celular , Extratos Celulares/química , Sistema Livre de Células/química , Sistema Livre de Células/metabolismo , Ciclina B/genética , Inibidores Enzimáticos/farmacologia , Feminino , Genes Reguladores/genética , Fator Promotor de Maturação/genética , Fator Promotor de Maturação/metabolismo , Oócitos/química , Fosforilação/efeitos dos fármacos , Proteínas Serina-Treonina Quinases , Processamento Pós-Transcricional do RNA/fisiologia , Proteínas de Ligação a RNA/efeitos dos fármacos , Proteínas de Ligação a RNA/genética , Proteínas Recombinantes de Fusão/genética , Proteínas de Xenopus/efeitos dos fármacos , Proteínas de Xenopus/genética , Xenopus laevis
17.
Mech Dev ; 120(3): 337-48, 2003 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-12591603

RESUMO

We have used antisense morpholino oligos to establish the developmental roles of three Xsox17 proteins in Xenopus development (Xsox17alpha(1), alpha(2) and beta). We show that their synthesis can be inhibited with modest amounts of oligo. The inhibition of each individually produces defects in late midgut development. Loss of activity of the Xsox17alpha proteins additionally inhibits hindgut formation, and inhibiting Xsox17alpha(1) disrupts foregut development with variable penetrance. When all Xsox17 activity is inhibited cell movements are halted during late gastrulation and the transcription of several endodermally expressed genes is reduced. Thus the Xsox17 proteins have redundant roles in early development of the endoderm and partly distinct roles during later organogenesis.


Assuntos
Endoderma/fisiologia , Proteínas de Grupo de Alta Mobilidade , Proteínas/genética , Proteínas de Xenopus/genética , Xenopus/embriologia , Regiões 5' não Traduzidas , Animais , Movimento Celular/genética , Proteínas de Ligação a DNA/genética , Sistema Digestório/embriologia , Anormalidades do Sistema Digestório , Embrião não Mamífero , Regulação da Expressão Gênica no Desenvolvimento/efeitos dos fármacos , Fator 1-beta Nuclear de Hepatócito , Técnicas In Vitro , Larva , Família Multigênica , Oligonucleotídeos Antissenso/farmacologia , Fenótipo , Biossíntese de Proteínas , Proteínas/metabolismo , Fatores de Transcrição SOXF , Fatores de Transcrição/efeitos dos fármacos , Fatores de Transcrição/genética , Xenopus/genética , Proteínas de Xenopus/efeitos dos fármacos , Proteínas de Xenopus/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA